Biogen (NASDAQ:BIIB) Releases FY24 Earnings Guidance
Biogen (NASDAQ:BIIB – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $15.00-16.00 for the period, compared to the consensus EPS estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue estimate of $9.47 billion. Biogen also updated its […]